Package Leaflet: Information for the User
Paracetamol Pensa 650 mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Paracetamol Pensa belongs to a group of medicines called analgesics and antipyretics.
This medicine is indicated for the symptomatic treatment of mild or moderate pain and to reduce fever.
Do not take Paracetamol Pensa
Warnings and precautions
Do not take more than the recommended dose in section 3.
If the pain persists for more than 5 days (3 days for children), the fever for more than 3 days, or if the pain or fever worsen or other symptoms appear, you should stop treatment and consult a doctor.
Paracetamol Pensa should not be given to children under 6 years of age because it does not allow for dosing of amounts less than 325 mg of paracetamol per dose (half a tablet). For administration of the indicated doses in this population, other presentations should be used.
The use of paracetamol in patients who habitually consume alcohol (three or more alcoholic beverages per day) may cause liver damage.
In chronic alcoholics, the precaution should be taken not to take more than 2 g/day of paracetamol.
In patients with kidney, heart, or lung disease, and in patients with anemia, consult your doctor before taking the medicine.
If you are going to have any diagnostic tests (including blood tests, urine tests, skin tests that use allergens, etc...), inform your doctor that you are taking this medicine, as it may alter the results.
During treatment with Paracetamol Pensa, inform your doctor immediately if:
If you have severe diseases, such as severe renal failure or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you have malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A serious disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling unwell (nausea) and vomiting.
Other medicines and Paracetamol Pensa
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Paracetamol may interact with the following medicines:
Do not use with other analgesics (pain-relieving medicines) without consulting your doctor.
Taking Paracetamol Pensa with food and drinks
The use of paracetamol in patients who habitually consume alcohol (three or more alcoholic beverages per day - beer, wine, liquor...) may cause liver damage.
Consult your doctor or pharmacist before taking any medicine.
Taking medicines during pregnancy can be dangerous for the embryo and the fetus. If you are pregnant or think you may be pregnant, consult your doctor before taking Paracetamol.
If necessary, Paracetamol Pensa can be used during pregnancy. You should use the lowest possible dose that reduces the pain or fever and use it for the shortest possible time. Contact your doctor if the pain or fever does not decrease or if you need to take the medicine more frequently.
Paracetamol is excreted in breast milk, so breastfeeding women should consult their doctor before using this medicine.
No effects have been described that affect driving and using machines.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Remember to take your medicine.
Your doctor will indicate the duration of your treatment with Paracetamol. If the pain persists for more than 5 days (3 days for children), the fever for more than 3 days, or if the pain or fever worsen or other symptoms appear, you should stop treatment and consult a doctor.
Use in adults: the recommended dose for adults is half to 1 tablet (325 to 650 mg) every 4-6 hours. Do not take more than 6 tablets every 24 hours.
Use in patients with liver or kidney disease: they should consult their doctor.
Use in children and adolescents
Children under 6 years: other presentations should be used because Paracetamol Pensa 650 mg contains more than the dose that should be administered to these children.
Children from6 to11 years: the usual dose is half a tablet (325 mg), every 4-6 hours. Do not take more than 2 and a half tablets (1.625 mg) every 24 hours.
Adolescents over 12 years: the usual dose is half to 1 tablet, every 4-6 hours. Do not take more than 5 tablets every 24 hours.
Method of administration
The tablets should be taken orally with a glass of water, and if you want to administer half the dose of the tablet, it should be split at the score line.
If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.
If you take more Paracetamol Pensa than you should
If you have taken more Paracetamol than you should, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 5620420.
If you have ingested an overdose, you should go quickly to a medical center, even if you do not have symptoms, since they often do not appear until 3 days after ingestion of the overdose, even in cases of severe poisoning.
The symptoms of overdose may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), and abdominal pain.
Treatment of overdose is most effective if started within 4 hours of taking the medicine.
Patients treated with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
If you forget to take Paracetamol Pensa
Do not take a double dose to make up for forgotten doses, simply take the forgotten dose when you remember and take the next doses with the indicated time interval (4-6 hours).
If you stop taking Paracetamol Pensa
Do not stop treatment before it is indicated by your doctor, as the medicine may not have the desired effect.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Paracetamol Pensa can cause side effects, although not everybody gets them.
Paracetamol may damage the liver at high doses or with prolonged treatment. Skin rashes and blood disorders, as well as kidney disorders, may also appear.
Very rare cases of serious skin reactions have been reported.
Frequency not known (cannot be estimated from the available data): A serious disease that can make the blood more acidic (called metabolic acidosis) in patients with severe disease using paracetamol (see section 2).
If you think any of the side effects you are experiencing is serious, or if you notice any side effects not mentioned in this leaflet, tell your doctor or pharmacist.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Health Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Paracetamol Pensa 650 mg tablets EFG
Appearance of the product and pack contents
Paracetamol Pensa 650 mg tablets are presented in the form of elongated, white, biconvex, and scored tablets. Each pack contains 20 or 40 tablets.
Marketing authorisation holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Towa Pharmaceutical Europe, S.L.
C/ de Sant Martí 75-97
08107 Martorelles (Barcelona)
Spain
Date of last revision of this leaflet:January 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es